Peripheral antinociceptive action of morphine and the synergistic interaction with lamotrigine

Anesthesiology

Volumn 96, Issue 4, 2002, Pages 921-925

  Argüelles, Carlos F ^a   Torres López, Jorge E ^b   Granados Soto, Vinicio ^c  

^a SECRETARÍA DE SALUD   (Mexico)

^b UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; GLUTAMIC ACID; LAMOTRIGINE; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MALE; MORPHINE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; TRIAZINES;

EID: 0036204292     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200204000-00020     Document Type: Article

References (48)

1. 2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes
2. Effects of intrathecally administered lamotrigine, a glutamate release inhibitor, on short- and long-term models of hyperalgesia in rats
3. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain
4. Lamotrigine control of central pain
5. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: Results from a double-blind placebo controlled crossover trial
6. Analgesic effects of lamotrigine and phenytoin on cold-induced pain: A crossover placebo-controlled study in healthy volunteers
7. Lamotrigine can remove the pain associated with painful diabetic neuropathy
8. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: A randomized, double-blind, placebo controlled trial
9. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: Neurochemical studies on the mechanism of action
10. Lamotrigine in the treatment of chronic refractary neuropathic pain
11. Ethical guidelines for investigations on experimental pain in conscious animals
12. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test
13. Sildenafil produces antinociception and increases morphine antinociception in the formalin test
14. Statistical analysis of drug-drug and site-site interactions with isobolograms
15. Theory and statistics of detecting synergy between two active drugs: Cocaine and buprenorphine
16. The molecular mechanism of peripheral morphine analgesia: Stimulation of the cGMP system via nitric oxide release
17. Evidence for the involvement of nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test
18. Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw
19. Neuroligand-evoked calcium-dependent release of excitatory amino acids from Schwann cells
20. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
21. Localization and activation of glutamate receptors in unmielinated axons of the rat glabrous skin
22. Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test
23. Intraplantar injection of dextrorphan, ketamine or nemantine attenuates formalin-induced behaviors
24. Evidence for the interaction of glutamate and NK1 receptors in the periphery
25. An in vivo investigation of the action of lamotrigine on neuronal voltage-activated sodium channels
26. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex
27. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurons
28. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury
29. Peripheral opioid receptors mediating antinociception on inflammation: Evidence for involvement of mu, delta and kappa receptors
30. Opioid receptors on peripheral sensory axons
31. Prostaglandin hyperalgesia: The peripheral analgesic activity of morphine, enkephalins and opioid antagonists
32. Opiates inhibit the discharges of fine afferent units from inflamed knee joints of the cats
33. Involvement of the mu-opiate receptor in peripheral analgesia
34. Peripheral mechanisms of opioid analgesia
35. Peripheral opioid modulation of pain and inflammation in the formalin test
36. + current in nociceptors
37. Substance P release from knee joint afferent terminals: Modulation by opioids
38. Substancia gelatinosa neurons hyperpolarized in vitro by enkephalin
39. + channel blocker antagonizes morphine analgesia
40. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan
41. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat
42. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine
43. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval
44. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn
45. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: Binding at μ-opioid receptors
46. Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine
47. Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test
48. Lamotrigine reduces total postoperative analgesic requirement: A randomized double-blind placebo-controlled pilot study